18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
connection with the quarterly report of American
Biogenetic Sciences, Inc. (the
Company) on Form 10-Q for the period ended June 30, 2012 (the
Report), as filed with the Securities and Exchange Commission on the date
hereof, I, Richard Rubin, CEO and CFO of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
/s/ Richard Rubin
CEO, CFO and Chairman
Dated: September 27, 2012
A signed original of this written
statement required by Section 906 has been provided to American Biogenetic Sciences, Inc. and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon request.